Leaving patients to their own devices? Smart technology, safety and therapeutic relationships
Open Access
- 6 March 2018
- journal article
- research article
- Published by Springer Nature in BMC Medical Ethics
- Vol. 19 (1) , 1-6
Abstract
This debate article explores how smart technologies may create a double-edged sword for patient safety and effective therapeutic relationships. Increasing utilization of health monitoring devices by patients will likely become an important aspect of self-care and preventive medicine. It may also help to enhance accurate symptom reports, diagnoses, and prompt referral to specialist care where appropriate. However, the development, marketing, and use of such technology raise significant ethical implications for therapeutic relationships and patient safety. Drawing on lessons learned from other direct-to-consumer health products such as genetic testing, this article explores how smart technology can also pose regulatory challenges and encourage overutilization of healthcare services. In order for smart technology to promote safer care and effective therapeutic encounters, the technology and its utilization must be safe. This article argues for unified regulatory guidelines and better education for both healthcare providers and patients regarding the benefits and risks of these devices.Keywords
Funding Information
- British High Commission and British Council
- National University of Singapore
This publication has 31 references indexed in Scilit:
- What's trust got to do with it? Revisiting opioid contractsJournal of Medical Ethics, 2013
- Medical Apps: Public and Academic PerspectivesPerspectives in Biology and Medicine, 2013
- The regulation of mobile health applicationsBMC Medicine, 2012
- Safely Doing Less: A Missing Component of the Patient Safety DialoguePediatrics, 2011
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskNew England Journal of Medicine, 2011
- Making existing technology safer in healthcareQuality and Safety in Health Care, 2010
- A Critical Appraisal of the Scientific Basis of Commercial Genomic Profiles Used to Assess Health Risks and Personalize Health InterventionsThe American Journal of Human Genetics, 2008
- Direct to consumer medical tests are offered in United StatesBMJ, 2006
- Trust and Pharmaco-Vigilance in Pain MedicinePain Medicine, 2005
- Patients' memory for medical informationJournal of the Royal Society of Medicine, 2003